Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could oral cancer surgery become a Same-Day procedure?

NCT ID NCT03545256

Recruiting now Disease control Sponsor: University Hospital, Montpellier Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study is testing whether people with early-stage oral or throat cancer (T1-N0 or T2-N0) can safely have their tumor removed as an outpatient, going home the same day. The procedure also includes a sentinel lymph node biopsy to check for cancer spread. Researchers will track how many patients need to be admitted or readmitted within 10 days due to complications. About 25-30 adults with operable squamous cell carcinoma of the oral cavity or oropharynx are being enrolled.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
outpatient surgery with sentinel lymph node biopsy
What this could lead to
If successful, this could show that outpatient surgery is a safe and practical option for certain early-stage oral cancers, reducing hospital stays and healthcare costs.
What could go wrong
This is a very small pilot study (25-30 people) with no comparison group, so results may not apply broadly. Complications could still require unplanned hospital admission.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER T1-N0 OR T2-N0 OF THE ORAL CAVITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Head and Neck Neoplasms Lymphatic Metastasis oral cavity cancer oral cavity carcinoma oral cavity squamous cell carcinoma oropharyngeal carcinoma oropharynx squamous cell carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER T1-N0 OR T2-N0 OF THE ORAL CAVITY

Contacts and locations

Locations

  • Gui de Chauliac Hospital, ENT Department 80 rue Augustin Fliche

    RECRUITING

    Montpellier, Hérault, 34295, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.